OOIR: Observatory of International Research

Papers

(The H4-Index of Expert Review of Anti-Infective Therapy is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials	193
Efficacy and acceptability of different anti-fungal interventions in oropharyngeal or esophageal candidiasis in HIV co-infected adults: a pilot network meta-analysis	84
Optic and peripheral neuropathy associated with short and prolonged administration of tedizolid: a review	67
Part 1: Understanding the role of Malassezia spp. in skin disorders: Malassezia yeasts as commensal or pathogenic organisms of human and a	61
Antiviral drugs for coronavirus disease 2019 (COVID-19): a systematic review with network meta-analysis	60
Neonatal ocular prophylaxis in the United States: is it still necessary?	60
The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies	60
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin	50
Sulbactam-durlobactam for the treatment of Acinetobacter baumannii-calcoaceticus complex	49
The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis	40
A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future	40
Visceral leishmaniasis elimination in India: progress and the road ahead	40
Nanomaterials as drug delivery systems with antibacterial properties: current trends and future priorities	38
NSAIDs/nitazoxanide/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects	38
Preventing healthcare-related infections among older adults: a focus on cross-transmission of antibiotic-resistant bacteria	36
The emergence of Japanese encephalitis as a public health concern in New South Wales Australia	36
Nontuberculous mycobacterial pulmonary disease and the potential role of SPR720	36
Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines	36
Multidrug-resistant Klebsiella pneumoniae: mechanisms of resistance including updated data for novel β-lactam-β-lactamase inhibitor combinations	35
Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies	34
Tineas caused by hedgehogs due to Trichophyton erinacei an ascending agent of dermatophytosis	33
Hypoalbuminemia as a predictor of severe dengue: a systematic review and meta-analysis	31
New and emerging roles for inhalational and direct antifungal drug delivery approaches for treatment of invasive fungal infections	31
Accuracy of gradient diffusion method for susceptibility testing of dalbavancin and comparators	31
Reemergence of monkeypox: prevention and management	31

Safety and efficacy of Paxlovid in the treatment of adults with mild to moderate COVID-19 during the omicron epidemic: a multicentre study from China	30
IL28B, TLR7 SNPs, and cytomegalovirus infection are risk factors for advanced liver disease in chronic hepatitis C patients	29
Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials	29